1. Home
  2. LGCB vs ATHA Comparison

LGCB vs ATHA Comparison

Compare LGCB & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LGCB

Linkage Global Inc

HOLD

Current Price

$1.78

Market Cap

23.4M

Sector

N/A

ML Signal

HOLD

Logo Athira Pharma Inc.

ATHA

Athira Pharma Inc.

HOLD

Current Price

$6.75

Market Cap

26.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGCB
ATHA
Founded
2011
2011
Country
Japan
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.4M
26.0M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
LGCB
ATHA
Price
$1.78
$6.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
78.6K
3.2M
Earning Date
07-03-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,993,265.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.80
N/A
52 Week Low
$1.22
$2.20
52 Week High
$6.83
$8.36

Technical Indicators

Market Signals
Indicator
LGCB
ATHA
Relative Strength Index (RSI) 45.82 60.50
Support Level $1.75 $6.41
Resistance Level $2.17 $7.45
Average True Range (ATR) 0.16 0.66
MACD 0.00 -0.03
Stochastic Oscillator 29.17 43.57

Price Performance

Historical Comparison
LGCB
ATHA

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

Share on Social Networks: